Discover 1,919 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,919
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
FeaturedActive & Responsive
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics
Sex: All
Age: 18+
Code: NCT07209475
Recruiting
Active & ResponsiveNew
A Study of DII235 in Adults With Elevated Lipoprotein(a)
for
Lipoprotein Disorder
Location: 9 recruiting locations
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07235046
Phase2, Recruiting
Active & ResponsiveNew
Noninvasive Therapy for Tinnitus
for
Tinnitus, Tinnitus, Subjective
Location: 1 recruiting location
Sponsor: Restorear Devices LLC
Sex: All
Age: 18+
Code: NCT07071480
Recruiting
Active & ResponsiveNew
Brain NAD in Alzheimer's Disease
for
Alzheimer Disease (AD)
Location: 1 recruiting location
Sponsor: Florida Atlantic University
Sex: All
Age: 65 - 70+
Code: NCT07127510
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
Taldefgrobep Alfa in Adults With Overweight and Obesity
for
Obesity, Overweight
Location: 10 recruiting locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 65
Code: NCT07281495
Phase2, Recruiting
Active & Responsive
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
for
Atherosclerotic Cardiovascular Disease (ASCVD)
Location: 25 recruiting locations
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06813911
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06589986
Phase3, Recruiting
Active & Responsive
A Study of RSLV-132 in Females With Sjögren's Disease